NATURAL CAPSULES LIMITED Share Price
NATURAL CAPSULES LIMITED Share Price Today
As of 5 Jul 2026, NATURAL CAPSULES LIMITED share price is ₹152.45. The stock opened at ₹151.99, compared to its previous close of ₹153.34. During today's trading session, NATURAL CAPSULES LIMITED share price moved in the range of ₹151.90 to ₹154.50, with an average price of ₹153.20 for the day. Looking at its last 52-week, the stock has touched a low of ₹136.36 and a high of ₹296.00. On the performance front, NATURAL CAPSULES LIMITED share price has declined by 22.88% over the last six months and is down 30.58% on a year-on-year basis.
NATURAL CAPSULES LIMITED Returns Calculator
NATURAL CAPSULES LIMITED Shareholder Returns
NATURAL CAPSULES LIMITED Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
NATURAL CAPSULES LIMITED Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹169.21 | ₹155.42 | ₹172.37 | ₹135.07 |
| Other Income | ₹0.70 | ₹1.94 | ₹0.57 | ₹1.01 |
| Total Revenue | ₹169.91 | ₹157.36 | ₹172.94 | ₹136.08 |
| Total Expenses | ₹167.12 | ₹149.30 | ₹147.95 | ₹116.69 |
| Profit Before Tax | ₹2.79 | ₹8.05 | ₹24.99 | ₹19.39 |
| Tax | ₹2.17 | ₹2.50 | ₹6.55 | ₹5.47 |
| Profit After Tax | ₹0.62 | ₹5.55 | ₹18.45 | ₹13.91 |
| EPS - Basic | ₹0.23 | ₹6.25 | ₹19.86 | ₹19.56 |
| EPS - Diluted | ₹0.23 | ₹6.25 | ₹19.86 | ₹19.56 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹2.79 | ₹8.05 | ₹24.99 | ₹19.39 |
| Income before WC changes | ₹18.74 | ₹21.60 | ₹35.26 | ₹25.64 |
| Change in Assets | -₹8.10 | -₹22.45 | -₹26.70 | -₹24.55 |
| Change in Liabilities | ₹18.18 | -₹5.53 | ₹14.12 | ₹3.13 |
| Change in WC | ₹10.08 | -₹27.98 | -₹12.58 | -₹21.42 |
| Cash flow from Operations | ₹26.75 | -₹8.35 | ₹17.22 | -₹0.52 |
| Cash flow from Investing | -₹44.48 | -₹72.59 | -₹104.63 | -₹45.88 |
| Cash flow from Financing | ₹16.17 | ₹81.72 | ₹87.49 | ₹47.70 |
| Total Cash Flow | -₹1.57 | ₹0.78 | ₹0.08 | ₹1.30 |
| Cash (Start of the year) | ₹2.25 | ₹1.48 | ₹1.40 | ₹0.10 |
| Cash (End of the year) | ₹0.69 | ₹2.25 | ₹1.48 | ₹1.40 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹289.76 | ₹252.76 | ₹187.25 | ₹88.69 |
| Current Assets | ₹129.59 | ₹123.77 | ₹101.51 | ₹75.58 |
| Total Assets | ₹419.35 | ₹376.53 | ₹288.76 | ₹164.28 |
| Current Liabilities | ₹99.99 | ₹76.49 | ₹66.94 | ₹44.77 |
| Net Current Asset | ₹29.59 | ₹47.28 | ₹34.56 | ₹30.82 |
| Non-Current Liabilities | ₹62.20 | ₹71.23 | ₹73.57 | ₹36.53 |
| Equity Capital | ₹257.16 | ₹228.80 | ₹148.25 | ₹82.98 |
| Total Equity & Liabilities | ₹419.35 | ₹376.53 | ₹288.76 | ₹164.28 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹167.94 | ₹153.81 | ₹172.87 | ₹135.07 |
| Other Income | ₹4.24 | ₹3.15 | ₹1.07 | ₹0.93 |
| Total Revenue | ₹172.17 | ₹156.95 | ₹173.93 | ₹136.00 |
| Total Expenses | ₹162.88 | ₹146.56 | ₹148.19 | ₹116.57 |
| Profit Before Tax | ₹9.30 | ₹10.39 | ₹25.74 | ₹19.43 |
| Tax | ₹2.59 | ₹2.59 | ₹6.55 | ₹5.47 |
| Profit After Tax | ₹6.71 | ₹7.81 | ₹19.20 | ₹13.95 |
| EPS - Basic | ₹6.43 | ₹8.67 | ₹20.68 | ₹19.62 |
| EPS - Diluted | ₹6.43 | ₹8.67 | ₹20.68 | ₹19.62 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹9.30 | ₹10.39 | ₹25.74 | ₹19.43 |
| Income before WC changes | ₹20.23 | ₹22.35 | ₹35.64 | ₹25.76 |
| Change in Assets | -₹7.54 | -₹14.87 | -₹18.76 | -₹19.80 |
| Change in Liabilities | ₹7.42 | -₹0.11 | ₹8.68 | ₹3.87 |
| Change in WC | -₹0.12 | -₹14.99 | -₹10.09 | -₹15.92 |
| Cash flow from Operations | ₹18.03 | ₹5.40 | ₹20.10 | ₹5.09 |
| Cash flow from Investing | -₹34.37 | -₹10.84 | -₹55.42 | -₹30.42 |
| Cash flow from Financing | ₹14.81 | ₹7.23 | ₹34.45 | ₹26.51 |
| Total Cash Flow | -₹1.53 | ₹1.79 | -₹0.87 | ₹1.18 |
| Cash (Start of the year) | ₹2.19 | ₹0.40 | ₹1.28 | ₹0.09 |
| Cash (End of the year) | ₹0.67 | ₹2.19 | ₹0.40 | ₹1.28 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹171.46 | ₹140.03 | ₹135.75 | ₹86.07 |
| Current Assets | ₹96.62 | ₹91.23 | ₹74.65 | ₹57.42 |
| Total Assets | ₹268.08 | ₹231.26 | ₹210.40 | ₹143.49 |
| Current Liabilities | ₹75.47 | ₹69.54 | ₹60.15 | ₹43.41 |
| Net Current Asset | ₹21.15 | ₹21.69 | ₹14.50 | ₹14.01 |
| Non-Current Liabilities | ₹26.29 | ₹29.86 | ₹26.20 | ₹17.03 |
| Equity Capital | ₹166.32 | ₹131.86 | ₹124.05 | ₹83.05 |
| Total Equity & Liabilities | ₹268.08 | ₹231.26 | ₹210.40 | ₹143.49 |
About NATURAL CAPSULES LIMITED
Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in manufacturing an array of capsules, including hard gelatin capsules, vegetarian capsules, and various specialty variants. The Company offers a diverse range of capsule products to both domestic and international markets, serving the pharmaceutical and nutraceutical industries. Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. It has two manufacturing facilities that are located in Bengaluru and Puducherry.
NATURAL CAPSULES LIMITED Financial Highlights
- Revenue: NATURAL CAPSULES LIMITED reported revenue of ₹188.93 crore in FY26 vs ₹169.91 crore in FY25. It showed an increase of 11.19% on a yearly basis.
- Operating Profit: NATURAL CAPSULES LIMITED reported an operating loss of ₹27.92 crore in FY26 vs ₹2.79 crore in FY25. It showed a decrease of 1,100.72% on a year-on-year basis.
- Net Profit: NATURAL CAPSULES LIMITED reported a net loss of ₹24.66 crore in FY26 vs ₹0.62 crore in FY25. It showed a decrease of 4,077.42% on a yearly basis.
NATURAL CAPSULES LIMITED Quarterly Result Highlights
- NATURAL CAPSULES LIMITED reported revenue of ₹59.21 crore in Mar 2026, compared with ₹38.20 crore in Dec 2025, representing an increase of 55.00% on a quarter-on-quarter (QoQ) basis.
- NATURAL CAPSULES LIMITED reported an operating loss of ₹5.08 crore in Mar 2026, compared with ₹9.08 crore in Dec 2025, representing an increase of 44.05% on a quarter-on-quarter (QoQ) basis.
- NATURAL CAPSULES LIMITED reported a loss of ₹4.98 crore in Mar 2026, compared with ₹7.12 crore in Dec 2025, reflecting an increase of 30.06% on a QoQ basis.
- The earnings per share (EPS) of NATURAL CAPSULES LIMITED stood at ₹0.23 during Mar 2026.
Similar Stocks
FAQs on NATURAL CAPSULES LIMITED Share Price
What is NATURAL CAPSULES LIMITED share price today?
NATURAL CAPSULES LIMITED share price is ₹152.45 as on 03 Jul, 2026, 15:46 IST.
How has the NATURAL CAPSULES LIMITED share price performed in the past?
In the last 1 year, NATURAL CAPSULES LIMITED delivered a return of -30.58%. The NATURAL CAPSULES LIMITED share price hit a high of ₹296.00 and low of ₹136.36.
How much is the Mutual Fund shareholding in NATURAL CAPSULES LIMITED shares?
The Mutual Fund Shareholding in NATURAL CAPSULES LIMITED was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of NATURAL CAPSULES LIMITED shares ?
The 52-week high and low of NATURAL CAPSULES LIMITED share is ₹296.00 and ₹136.36 as of 03 Jul, 2026.
What is the market cap of NATURAL CAPSULES LIMITED?
The market capitalisation of NATURAL CAPSULES LIMITED is ₹160.85 Crores as on 03 Jul, 2026.
What are the stock symbols of NATURAL CAPSULES LIMITED?
The stock symbol of NATURAL CAPSULES LIMITED is NATCAPSUQ on the NSE, 524654 on the BSE, and the ISIN is INE936B01015.
What was yesterday's closing price of NATURAL CAPSULES LIMITED shares ?
NATURAL CAPSULES LIMITED shares closed yesterday at ₹153.34 on NSE & ₹154.50 on BSE
How to buy NATURAL CAPSULES LIMITED shares?
To buy NATURAL CAPSULES LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy NATURAL CAPSULES LIMITED shares on Holidays?
No, shares of NATURAL CAPSULES LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell NATURAL CAPSULES LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of NATURAL CAPSULES LIMITED?
The PE and PB ratio of NATURAL CAPSULES LIMITED is -6.52 and 0.73 respectively, as on 03 Jul, 2026, 15:46 IST.